Device, system, and method for controllably reducing inflammatory mediators in a subject
First Claim
Patent Images
1. A method for treating an inflammatory disease or condition in a subject comprising:
- providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, the controller configured to control interaction between one or more reactive components and the one or more inflammatory mediators, the one or more reactive components configured to alter a functional structure of the one or more inflammatory mediators in the peripheral blood, wherein the controller is configured to control the interaction between the one or more reactive components and the one or more inflammatory mediators to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, and the controller is in communication with a reservoir configured to release the one or more reactive components into the peripheral blood, andflowing blood through the device to treat the inflammatory disease or condition in the subject.
2 Assignments
0 Petitions
Accused Products
Abstract
Devices, systems, and methods are provided for controlling an inflammatory response in a subject. Devices, systems, and methods are provided that alter the functional structure of one or more inflammatory mediators in the peripheral blood of the subject. The device or system is useful in a method for treating an inflammatory disease or condition in the subject.
100 Citations
48 Claims
-
1. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, the controller configured to control interaction between one or more reactive components and the one or more inflammatory mediators, the one or more reactive components configured to alter a functional structure of the one or more inflammatory mediators in the peripheral blood, wherein the controller is configured to control the interaction between the one or more reactive components and the one or more inflammatory mediators to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, and the controller is in communication with a reservoir configured to release the one or more reactive components into the peripheral blood, andflowing blood through the device to treat the inflammatory disease or condition in the subject. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)
-
-
29. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the target value includes a desired ratio of concentrations of two or more inflammatory mediators in the peripheral blood.
-
-
30. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the sensor and the controller are configured to control levels of the one or more inflammatory mediators to limit a deviation from the target value. - View Dependent Claims (31)
-
-
32. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the sensor includes a physical sensor including one or more of an aptamer, antibody, or receptor.
-
-
33. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the sensor includes a physical sensor including one or more of a recognition-based substrate, an aptamer-based substrate, an antibody-based substrate, surface plasmon resonance, genetically-modified cells, or genetically-modified cells with receptor-linked signaling. - View Dependent Claims (34)
-
-
35. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the sensor is configured to detect cytokines, T-lymphocytes, B-lymphocytes, or antibodies.
-
-
36. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the sensor is further configured to detect body temperature, vital signs, edema, oxygen level, or pathogen/toxin level of the subject.
-
-
37. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the one or more reactive components include one or more binding agents on a matrix adapted to the treatment chamber are configured to sequester at least one of the one or more inflammatory mediators from the blood and the one or more binding agents include one or more of antibodies, receptors, or cognates configured to bind to at least one of the one or more inflammatory mediators.
-
-
38. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the one or more reactive components include one or more binding agents on a matrix adapted to the treatment chamber are configured to sequester at least one of the one or more inflammatory mediators from the blood and the one or more binding agent includes at least one of lectin, binding protein, catalytic antibody, catalytic aptamer, protease conjugate, or photoactivatable agent conjugate.
-
-
39. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the one or more reactive components include one or more binding agents on a matrix adapted to the treatment chamber configured to sequester at least one of the one or more inflammatory mediators from the blood, and the matrix includes one or more of beads, cells, vesicles, filters, hydrogel polymers, microparticles, nanoparticles, adsorbent, or synthetic polymers. - View Dependent Claims (40)
-
-
41. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the one or more reactive components include one or more binding agents on a matrix adapted to the treatment chamber are configured to sequester at least one of the one or more inflammatory mediators from the blood and the matrix includes one or more of a lectin, binding protein, receptor, antibody, catalytic antibody, catalytic aptamer, protease conjugate, or photoactivatable agent conjugate.
-
-
42. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the one or more reactive components include one or more binding agents that decrease an activity of an intermediate that decrease the activity of one or more of TNF-α
, IL-1, IL-1β
, IL-6, IL-8, IL-10, IL-12, LPB, IFN-γ
, LIF, MIF, MIP-1, MCP-1, C3-a, C5-a, exotoxin, or endotoxin.
-
-
43. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a means for modulating a physiological effect of the one or more inflammatory mediators responsive to the controller, the controller configured to adjust the modulating means to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, wherein the means for modulating a physiological effect of the one or more inflammatory mediators includes one or more reactive components configured to alter a functional structure of the one or more inflammatory mediators in the peripheral blood wherein the one or more reactive components is configured to modulate an activity of one or more of anaphylatoxins, cytokines, chemokines, leukotrienes, prostaglandins, complement, coagulation factors, or proinflammatory cytokines.
-
-
44. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a treatment chamber configured to receive at least a portion of the peripheral blood through a flow route, the controller configured to control flow of peripheral blood through the flow route into the treatment chamber, and the treatment chamber including one or more reactive components configured to alter a functional structure of the one or more inflammatory mediators in the peripheral blood, the controller configured to adjust flow to the treatment chamber to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, and wherein the treatment chamber includes a source for producing the one or more reactive components. - View Dependent Claims (45, 46, 47)
-
-
48. A method for treating an inflammatory disease or condition in a subject comprising:
-
providing a device configured to communicate with at least a portion of a peripheral blood of the subject, the device including a sensor configured to detect one or more inflammatory mediators in peripheral blood of a subject;
a controller in communication with the sensor, a treatment chamber configured to receive at least a portion of the peripheral blood through a flow route, the controller configured to control flow of peripheral blood through the flow route into the treatment chamber, the treatment chamber including one or more reactive components configured to alter a functional structure of the one or more inflammatory mediators in the peripheral blood, the controller configured to adjust flow to the treatment chamber to achieve a target value of the detected one or more inflammatory mediators in the peripheral blood of the subject, andflowing blood through the device to treat the inflammatory disease or condition in the subject, and wherein the treatment chamber includes one or more reservoirs including one or more reactive components.
-
Specification